Literature DB >> 20864041

MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.

Jennifer M Doyle1, Jinlan Gao, Jiawei Wang, Maojun Yang, Patrick Ryan Potts.   

Abstract

The melanoma antigen (MAGE) family consists of more than 60 genes, many of which are cancer-testis antigens that are highly expressed in cancer and play a critical role in tumorigenesis. However, the biochemical and cellular functions of this enigmatic family of proteins have remained elusive. Here, we identify really interesting new gene (RING) domain proteins as binding partners for MAGE family proteins. Multiple MAGE family proteins bind E3 RING ubiquitin ligases with specificity. The crystal structure of one of these MAGE-RING complexes, MAGE-G1-NSE1, reveals structural insights into MAGE family proteins and their interaction with E3 RING ubiquitin ligases. Biochemical and cellular assays demonstrate that MAGE proteins enhance the ubiquitin ligase activity of RING domain proteins. For example, MAGE-C2-TRIM28 is shown to target p53 for degradation in a proteasome-dependent manner, consistent with its tumorigenic functions. These findings define a biochemical and cellular function for the MAGE protein family.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864041      PMCID: PMC4509788          DOI: 10.1016/j.molcel.2010.08.029

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-gamma, taxol and gamma-irradiation.

Authors:  Zoran M Cilensek; Fruma Yehiely; Rupinder K Kular; Louis P Deiss
Journal:  Cancer Biol Ther       Date:  2002 Jul-Aug       Impact factor: 4.742

2.  Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.

Authors:  Martin Bolli; Thomas Kocher; Michel Adamina; Ulrich Guller; Peter Dalquen; Philippe Haas; Martina Mirlacher; Franco Gambazzi; Felix Harder; Michael Heberer; Guido Sauter; Giulio C Spagnoli
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

3.  The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region.

Authors:  P Jay; C Rougeulle; A Massacrier; A Moncla; M G Mattei; P Malzac; N Roëckel; S Taviaux; J L Lefranc; P Cau; P Berta; M Lalande; F Muscatelli
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

4.  Expression of MAGE genes in primary and metastatic cutaneous melanoma.

Authors:  F Brasseur; D Rimoldi; D Liénard; B Lethé; S Carrel; F Arienti; L Suter; R Vanwijck; A Bourlond; Y Humblet
Journal:  Int J Cancer       Date:  1995-11-03       Impact factor: 7.396

5.  hMAGE-A1 overexpression reduces TNF-alpha cytotoxicity in ME-180 cells.

Authors:  Joo-Hung Park; Gee-Hye Kong; Soo-Woong Lee
Journal:  Mol Cells       Date:  2002-08-31       Impact factor: 5.034

6.  Nse1, Nse2, and a novel subunit of the Smc5-Smc6 complex, Nse3, play a crucial role in meiosis.

Authors:  Stephanie Pebernard; W Hayes McDonald; Yelena Pavlova; John R Yates; Michael N Boddy
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

7.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 8.  GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development.

Authors:  Vincent G Brichard; Diane Lejeune
Journal:  Vaccine       Date:  2007-09-27       Impact factor: 3.641

9.  A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination.

Authors:  Guang Yu Zhao; Eiichiro Sonoda; Louise J Barber; Hayato Oka; Yasuhiro Murakawa; Kouichi Yamada; Tsuyoshi Ikura; Xin Wang; Masahiko Kobayashi; Kenichi Yamamoto; Simon J Boulton; Shunichi Takeda
Journal:  Mol Cell       Date:  2007-03-09       Impact factor: 17.970

10.  TP53 allele loss, mutations and expression in malignant melanoma.

Authors:  V A Flørenes; T Oyjord; R Holm; M Skrede; A L Børresen; J M Nesland; O Fodstad
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more
  203 in total

1.  Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1.

Authors:  Neehar Bhatia; Bing Yang; Tony Z Xiao; Noel Peters; Michael F Hoffmann; B Jack Longley
Journal:  Arch Biochem Biophys       Date:  2011-01-28       Impact factor: 4.013

2.  H2A.Z-dependent regulation of cohesin dynamics on chromosome arms.

Authors:  Claudia Tapia-Alveal; Su-Jiun Lin; Aaron Yeoh; Omar J Jabado; Matthew J O'Connell
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

3.  A no-stop mutation in MAGEB4 is a possible cause of rare X-linked azoospermia and oligozoospermia in a consanguineous Turkish family.

Authors:  Ozlem Okutman; Jean Muller; Valerie Skory; Jean Marie Garnier; Angeline Gaucherot; Yoni Baert; Valérie Lamour; Munevver Serdarogullari; Meral Gultomruk; Albrecht Röpke; Sabine Kliesch; Viviana Herbepin; Isabelle Aknin; Moncef Benkhalifa; Marius Teletin; Emre Bakircioglu; Ellen Goossens; Nicolas Charlet-Berguerand; Mustafa Bahceci; Frank Tüttelmann; STéphane Viville
Journal:  J Assist Reprod Genet       Date:  2017-04-11       Impact factor: 3.412

4.  Cancer/Testis Antigen PASD1 Silences the Circadian Clock.

Authors:  Alicia K Michael; Stacy L Harvey; Patrick J Sammons; Amanda P Anderson; Hema M Kopalle; Alison H Banham; Carrie L Partch
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

5.  Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Authors:  Sachet A Shukla; Pavan Bachireddy; Bastian Schilling; Christina Galonska; Qian Zhan; Clyde Bango; Rupert Langer; Patrick C Lee; Daniel Gusenleitner; Derin B Keskin; Mehrtash Babadi; Arman Mohammad; Andreas Gnirke; Kendell Clement; Zachary J Cartun; Eliezer M Van Allen; Diana Miao; Ying Huang; Alexandra Snyder; Taha Merghoub; Jedd D Wolchok; Levi A Garraway; Alexander Meissner; Jeffrey S Weber; Nir Hacohen; Donna Neuberg; Patrick R Potts; George F Murphy; Christine G Lian; Dirk Schadendorf; F Stephen Hodi; Catherine J Wu
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

Review 6.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

7.  A ballsy search for cancer targets.

Authors:  Megan Scudellari
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

8.  Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.

Authors:  S Hartmann; U Kriegebaum; N Küchler; R C Brands; C Linz; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2013-02-21       Impact factor: 3.573

9.  MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair.

Authors:  Neehar Bhatia; Tony Z Xiao; Kimberly A Rosenthal; Imtiaz A Siddiqui; Saravanan Thiyagarajan; Brendan Smart; Qiao Meng; Cindy L Zuleger; Hasan Mukhtar; Shannon C Kenney; Mark R Albertini; B Jack Longley
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

10.  Necdin enhances myoblasts survival by facilitating the degradation of the mediator of apoptosis CCAR1/CARP1.

Authors:  Stephanie François; Cristina D'Orlando; Tiziana Fatone; Thierry Touvier; Patrizia Pessina; Raffaella Meneveri; Silvia Brunelli
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.